Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

AGIOAGIO
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in AGIOS PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 1.2M shares of AGIO (AGIOS PHARMACEUTICALS INC), worth $42.7M as of 2026-Q2. The position was increased (+42.8% shares). AGIO represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$42.7M

Current Shares

1.2M

Total Value Change

+$24.1M

Total Shares Change

+583,762

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+42.8%
$42.7M0.0%$37.11
39
2026-Q1
Decreased
805,776
-22.1%
$27.3M0.0%$33.83
0
2025-Q4
Increased
1M
+28.5%
$28.1M0.0%$27.22
36
2025-Q3
Increased
804,766
+24.2%
$32.3M0.0%$40.14
35
2025-Q2
Decreased
648,061
-1.6%
$21.6M0.0%$33.26
0
2025-Q1
Increased
658,652
+16.1%
$19.3M0.0%$29.30
33
2024-Q4
New
567,170
-
$18.6M0.0%$32.86
39

Other major holders of AGIO: BNP PARIBAS FINANCIAL MARKETS, FARALLON CAPITAL MANAGEMENT, L.L.C., VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used